ARCHIVES

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB May Determine Fate Of NCOG, Possibly Other Regional Groups; Simone Denies CCIRC Prejudice

May 8, 1981

Reagan’s Freeze Chills NCI Plan To Hire Outsiders

January 30, 1981

PRI Fires Gilden, Compten, Sues For $1 Million By May Be Out Of Recompetition; NCI Is “Neutral”

August 8, 1986

Uncertainty Lingers After NCI Meeting With Army; Activists Offer Advice

November 6, 1992

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991

Liver Transplants Extend Survival In Early-Stage Cancer

January 27, 2006